Skip to main content

BIOMARCADORES SINOVIALES Y SERICOS DE MAL PRONOSTICO EN ARTRITIS INDIFERENCIADAS DE INICIO. UN ESTUDIO LONGITUDINAL, PROSPECTIVO, DE 18 MESES DE SEGUIMIENTO.

PI17/00993

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2017
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)
Execution centre INSTITUTO DE INVESTIGACIONES BIOMEDICAS AUGUST PI I SUNYER (IDIBAPS)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritis

  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Ciudad, Laura|||0000-0002-5219-6792
  • Ramírez, Julio
  • Celis, Raquel|||0000-0002-5096-4532
  • Azuaga, Ana Belén
  • Cuervo, Andrea
  • Graell, Eduard|||0000-0002-4210-2721
  • Pérez-García, Carolina|||0000-0002-6695-6406
  • Diaz-Torne, Cesar|||0000-0001-6275-7699
  • Salvador, Georgina
  • Gómez-Puerta, Jose A.|||0000-0001-8177-702X
  • Haro, Isabel|||0000-0001-8677-2340
  • Sanmartí, Raimon|||0000-0002-8864-3806
  • Cañete, Juan D.|||0000-0003-2606-0573
  • Ballestar, Esteban|||0000-0002-1400-2440
Identifying predictive biomarkers at early stages of inflammatory arthritis is crucial for starting appropriate therapies to avoid poor outcomes. Monocytes (MOs) and macrophages, largely associated with arthritis, are contributors and sensors of inflammation through epigenetic modifications. In this study, we investigated associations between clinical features and DNA methylation in blood and synovial fluid (SF) MOs in a prospective cohort of patients with early inflammatory arthritis. DNA methylation profiles of undifferentiated arthritis (UA) blood MOs exhibited marked alterations in comparison with those from healthy donors. We identified additional differences both in blood and SF MOs after comparing patients with UA grouped by their future outcomes, i.e., good versus poor. Patient profiles in subsequent visits revealed a reversion toward a healthy level in both groups, those requiring disease-modifying antirheumatic drugs and those who remitted spontaneously. Changes in disease activity between visits also affected DNA methylation, which was partially concomitant in the SF of UA and in blood MOs of patients with rheumatoid arthritis. Epigenetic similarities between arthritis types allow a common prediction of disease activity. Our results constitute a resource of DNA methylation-based biomarkers of poor prognosis, disease activity, and treatment efficacy for the personalized clinical management of early inflammatory arthritis.